America February 4, 2026
primeGen US to Go Public in $1.5 Billion SPAC Deal
Biotech company PrimeGen US will go public in the United States through a $1.5 billion business combination with blank-check firm…
America February 4, 2026
Biotech company PrimeGen US will go public in the United States through a $1.5 billion business combination with blank-check firm…
By Rachel Moore
America July 30, 2024
GlaxoSmithKline announced Monday it will invest up to $7.2 billion in a biotech venture capital firm’s research and development pipeline,…
By Rihem Akkouche